XLO
Xilio Therapeutics, Inc.
Company overview
- Market capitalization
- $52.33M
- Employees
- 76
- Latest publication
- 2026-09-29
About Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 18,692,000USD | 12,648,000USD | 13,686,000USD | 19,066,000USD | 8,084,000USD | 2,930,000USD | 1,724,000USD | 2,263,000USD |
| Research Development | 14,559,000USD | 19,832,000USD | 18,122,000USD | 14,321,000USD | 15,330,000USD | 8,266,000USD | 8,836,000USD | 10,759,000USD |
| Selling General Administrative | 7,624,000USD | 6,928,000USD | 7,400,000USD | 6,674,000USD | 7,120,000USD | 8,515,000USD | 6,517,000USD | 6,307,000USD |
| General And Administrative Expenses | 7,624,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 22,183,000USD | 26,416,000USD | 25,522,000USD | 20,995,000USD | 7,120,000USD | 16,781,000USD | 15,353,000USD | 17,025,000USD |
| Operating Income | -3,491,000USD | -14,112,000USD | -11,836,000USD | -1,929,000USD | -14,366,000USD | -13,851,000USD | -13,629,000USD | -14,762,000USD |
| Total Other Income Expense Net | -2,882,000USD | 4,583,000USD | 22,196,000USD | -14,358,000USD | -1,478,000USD | 586,000USD | 536,000USD | 742,000USD |
| Net Income | -6,373,000USD | -9,529,000USD | 10,360,000USD | -16,287,000USD | -15,844,000USD | -13,265,000USD | -13,093,000USD | -14,020,000USD |
| Cost Of Revenue | — | 344,000USD | 323,000USD | 340,000USD | 15,330,000USD | — | 444,000USD | — |
| Gross Profit | — | 12,304,000USD | 13,686,000USD | 19,066,000USD | -7,246,000USD | 2,930,000USD | 1,724,000USD | 2,263,000USD |
| Selling And Marketing Expenses | — | 344,000USD | — | — | — | — | — | — |
| Income Before Tax | — | -9,529,000USD | 10,360,000USD | -16,287,000USD | -15,844,000USD | -13,265,000USD | -13,093,000USD | -14,020,000USD |
| Net Income From Continuing Ops | — | -9,529,000USD | 10,360,000USD | -16,287,000USD | -15,844,000USD | -13,265,000USD | -13,093,000USD | -14,020,000USD |
| Ebit | — | -14,112,000USD | -11,836,000USD | -1,929,000USD | -14,366,000USD | -13,851,000USD | -13,629,000USD | -14,803,000USD |
| Ebitda | — | -13,768,000USD | -11,513,000USD | -1,589,000USD | -13,985,000USD | -13,354,000USD | -13,254,000USD | -14,422,000USD |
| Depreciation And Amortization | — | 344,000USD | 323,000USD | 340,000USD | 381,000USD | 497,000USD | 375,000USD | 381,000USD |
| Reconciled Depreciation | — | 344,000USD | 323,000USD | 340,000USD | 381,000USD | 497,000USD | 375,000USD | 381,000USD |
| Unclassified Operating Expenses | — | — | — | — | -15,330,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 43,766,000USD | 6,344,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,541,000USD | 1,644,000USD | 1,900,000USD | 1,847,000USD | 1,499,000USD | 1,065,000USD | 240,000USD |
| Gross Profit | 42,225,000USD | 6,344,000USD | -1,900,000USD | -1,847,000USD | -1,499,000USD | -1,065,000USD | -240,000USD |
| Research Development | 56,039,000USD | 41,211,000USD | 52,136,000USD | 59,201,000USD | 51,188,000USD | 43,910,000USD | 14,256,000USD |
| Selling General Administrative | 29,709,000USD | 24,778,000USD | 26,997,000USD | 29,948,000USD | 23,856,000USD | 10,653,000USD | 4,771,000USD |
| Unclassified Operating Expenses | -1,541,000USD | — | — | — | — | -1,065,000USD | — |
| Total Operating Expenses | 84,207,000USD | 66,926,000USD | 79,133,000USD | 89,149,000USD | 75,044,000USD | 53,498,000USD | 18,787,000USD |
| Operating Income | -41,982,000USD | -60,582,000USD | -79,133,000USD | -89,149,000USD | -75,044,000USD | -54,563,000USD | -19,027,000USD |
| Income Before Tax | -35,036,000USD | -58,241,000USD | -76,404,000USD | -88,222,000USD | -75,800,000USD | -55,219,000USD | -17,311,000USD |
| Net Income | -35,036,000USD | -58,241,000USD | -76,404,000USD | -87,295,000USD | -74,301,000USD | -55,219,000USD | -17,311,000USD |
| Net Income From Continuing Ops | -35,036,000USD | -58,241,000USD | -81,215,000USD | -88,222,000USD | -75,800,000USD | -55,219,000USD | -17,311,000USD |
| Ebit | -41,982,000USD | -59,645,000USD | -79,133,000USD | -89,149,000USD | -75,044,000USD | -54,619,000USD | -17,311,000USD |
| Ebitda | -40,441,000USD | -58,001,000USD | -77,233,000USD | -87,302,000USD | -73,545,000USD | -53,554,000USD | -17,071,000USD |
| Depreciation And Amortization | 1,541,000USD | 1,644,000USD | 1,900,000USD | 1,847,000USD | 1,499,000USD | 1,065,000USD | 240,000USD |
| Reconciled Depreciation | 1,541,000USD | 1,644,000USD | 1,940,000USD | 1,847,000USD | 1,499,000USD | 1,065,000USD | 240,000USD |
| Total Other Income Expense Net | 6,946,000USD | 2,341,000USD | 2,729,000USD | 927,000USD | -756,000USD | -656,000USD | 1,716,000USD |
| Interest Expense | — | 100,000USD | 127,800USD | 927,000USD | 756,000USD | 600,000USD | 0USD |
| Income Tax Expense | — | — | -927,000USD | -927,000USD | -1,499,000USD | 858,703USD | 68,140USD |
| Non Operating Income Net Other | — | — | — | 927,000USD | -756,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -88,222,000USD | -75,800,000USD | -55,219,000USD | -17,311,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 154,254,000USD | 163,487,000USD | 154,685,000USD | 133,694,000USD | 133,813,000USD | 103,716,000USD | 71,075,000USD | 74,658,000USD |
| Cash And Equivalents | 136,040,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 145,468,000USD | 154,207,000USD | 145,027,000USD | 124,089,000USD | 123,716,000USD | 93,200,000USD | 60,234,000USD | 63,309,000USD |
| Other Current Assets | 3,428,000USD | 3,874,000USD | 2,496,000USD | 20,325,000USD | 2,165,000USD | 4,127,000USD | 4,943,000USD | 2,050,000USD |
| Total Liabilities | 81,990,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 34,198,000USD | 42,960,000USD | 56,273,000USD | 56,401,000USD | 53,260,000USD | 47,637,000USD | 27,261,000USD | 38,022,000USD |
| Other Current Liabilities | 7,854,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 72,264,000USD | 72,545,000USD | 35,273,000USD | -8,095,000USD | 7,069,000USD | 10,700,000USD | 17,598,000USD | 20,974,000USD |
| Total Equity Including Noncontrolling Interest | 72,264,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 22,603,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 6,967,000USD | 7,467,000USD | 7,851,000USD | 7,804,000USD | 8,303,000USD | 8,728,000USD | 9,059,000USD | 9,574,000USD |
| Accounts Payable | 2,315,000USD | 1,064,000USD | 3,168,000USD | 2,300,000USD | 4,097,000USD | 2,275,000USD | 2,574,000USD | 972,000USD |
| Short Term Debt | 1,426,000USD | 1,384,000USD | 1,343,000USD | 1,303,000USD | 1,264,000USD | 1,226,000USD | 1,188,000USD | 1,152,000USD |
| Common Stock | 1,000USD | 26,261,000USD | 36,893,000USD | 53,935,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Retained Earnings | -434,691,000USD | -428,318,000USD | -418,789,000USD | -429,149,000USD | -412,862,000USD | -397,018,000USD | -383,753,000USD | -370,660,000USD |
| Total Liab | — | 90,942,000USD | 119,412,000USD | 141,789,000USD | 126,744,000USD | 93,016,000USD | 53,477,000USD | 53,684,000USD |
| Other Current Liab | — | 8,970,000USD | 11,739,000USD | 8,952,000USD | 5,621,000USD | 3,883,000USD | 9,981,000USD | 9,793,000USD |
| Capital Stock | — | 0USD | 0USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Cash | — | 150,333,000USD | 137,531,000USD | 103,764,000USD | 121,551,000USD | 89,073,000USD | 55,291,000USD | 61,259,000USD |
| Cash And Short Term Investments | — | 150,333,000USD | 137,531,000USD | 103,764,000USD | 121,551,000USD | 89,073,000USD | 55,291,000USD | 61,259,000USD |
| Current Deferred Revenue | — | 31,542,000USD | 40,023,000USD | 43,846,000USD | 42,278,000USD | 40,253,000USD | 13,518,000USD | 26,105,000USD |
| Net Debt | — | -143,695,000USD | -130,577,000USD | -96,501,000USD | -113,985,000USD | -81,209,000USD | -47,149,000USD | -52,844,000USD |
| Short Long Term Debt Total | — | 6,638,000USD | 6,954,000USD | 7,263,000USD | 7,566,000USD | 7,864,000USD | 8,142,000USD | 8,415,000USD |
| Property Plant Equipment Gross | — | 16,564,000USD | 16,604,000USD | 16,264,000USD | 16,424,000USD | 16,469,000USD | 16,486,000USD | 16,634,000USD |
| Common Stock Shares Outstanding | — | 163,475,380shares | 83,591,090shares | 10,293,347shares | 3,701,994shares | 5,335,740shares | 4,619,701shares | 4,533,219shares |
| Non Current Assets Total | — | 9,280,000USD | 9,658,000USD | 9,605,000USD | 10,097,000USD | 10,516,000USD | 10,841,000USD | 11,349,000USD |
| Non Current Liabilities Total | — | 47,982,000USD | 63,139,000USD | 85,388,000USD | 73,484,000USD | 45,379,000USD | 26,216,000USD | 15,662,000USD |
| Non Current Liabilities Other | — | 1,000USD | 7,333,000USD | — | — | — | — | — |
| Non Currrent Assets Other | — | 1,813,000USD | 1,807,000USD | 1,801,000USD | 1,794,000USD | 1,788,000USD | 1,782,000USD | 1,775,000USD |
| Net Working Capital | — | 111,247,000USD | 88,754,000USD | 67,688,000USD | 70,456,000USD | 45,563,000USD | 32,973,000USD | 25,287,000USD |
| Unclassified Non Current Liabilities | — | 47,981,000USD | 55,806,000USD | 85,388,000USD | 73,484,000USD | 45,379,000USD | 26,216,000USD | 15,662,000USD |
| Unclassified Equity | — | 474,602,000USD | 417,169,000USD | 367,114,000USD | 419,921,000USD | 407,708,000USD | 401,341,000USD | 391,626,000USD |
| Net Receivables | — | — | 5,000,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 154,685,000USD | 71,075,000USD | 60,926,000USD | 139,165,000USD | 221,599,000USD | 36,317,000USD | 62,722,000USD |
| Other Current Assets | 2,496,000USD | 4,943,000USD | 3,423,000USD | 4,111,000USD | 4,464,000USD | 1,352,000USD | 2,259,000USD |
| Total Liab | 119,412,000USD | 53,477,000USD | 24,099,000USD | 33,518,000USD | 36,170,000USD | 41,602,000USD | 24,212,000USD |
| Total Stockholder Equity | 35,273,000USD | 17,598,000USD | 36,827,000USD | 105,647,000USD | 185,429,000USD | -5,285,000USD | 38,510,000USD |
| Other Current Liab | 11,739,000USD | 9,981,000USD | 11,592,000USD | 10,409,000USD | 8,751,000USD | 13,732,000USD | 2,689,000USD |
| Common Stock | 36,893,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 1,000USD | — |
| Capital Stock | 0USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 0USD | 0USD |
| Retained Earnings | -418,789,000USD | -383,753,000USD | -325,512,000USD | -249,108,000USD | -160,886,000USD | -85,086,000USD | -29,867,000USD |
| Cash | 137,531,000USD | 55,291,000USD | 44,704,000USD | 120,385,000USD | 198,053,000USD | 19,238,000USD | 48,845,000USD |
| Cash And Short Term Investments | 137,531,000USD | 55,291,000USD | 44,704,000USD | 120,385,000USD | 198,053,000USD | 19,238,000USD | 48,845,000USD |
| Total Current Assets | 145,027,000USD | 60,234,000USD | 48,127,000USD | 124,496,000USD | 202,517,000USD | 20,590,000USD | 51,104,000USD |
| Total Current Liabilities | 56,273,000USD | 27,261,000USD | 15,957,000USD | 21,119,000USD | 12,778,000USD | 22,155,000USD | 5,207,000USD |
| Current Deferred Revenue | 40,023,000USD | 13,518,000USD | — | — | 8,751,000USD | 13,732,000USD | — |
| Net Debt | -130,577,000USD | -47,149,000USD | -33,247,000USD | -100,446,000USD | -177,317,000USD | 2,648,000USD | -30,214,000USD |
| Short Term Debt | 1,343,000USD | 1,188,000USD | 3,315,000USD | 7,585,000USD | 883,000USD | 2,979,000USD | — |
| Short Long Term Debt Total | 6,954,000USD | 8,142,000USD | 11,457,000USD | 19,939,000USD | 20,736,000USD | 21,886,000USD | 18,631,000USD |
| Net Receivables | 5,000,000USD | — | — | 267,000USD | 393,000USD | — | — |
| Accounts Payable | 3,168,000USD | 2,574,000USD | 1,050,000USD | 3,125,000USD | 3,144,000USD | 5,444,000USD | 2,518,000USD |
| Property Plant Equipment Net | 7,851,000USD | 9,059,000USD | 11,201,000USD | 12,840,000USD | 13,900,000USD | 14,064,000USD | 9,873,000USD |
| Property Plant Equipment Gross | 16,604,000USD | 16,486,000USD | 16,928,000USD | 7,255,000USD | 16,309,000USD | 15,036,000USD | 10,203,000USD |
| Common Stock Shares Outstanding | 83,591,090shares | 3,822,245shares | 1,964,008shares | 27,392,087shares | 400,451shares | 37,413shares | 29,236shares |
| Non Current Assets Total | 9,658,000USD | 10,841,000USD | 12,799,000USD | 14,669,000USD | 19,081,999USD | 15,727,000USD | 11,618,000USD |
| Non Current Liabilities Total | 63,139,000USD | 26,216,000USD | 8,142,000USD | 12,399,000USD | 23,392,000USD | 19,447,000USD | 19,005,000USD |
| Non Current Liabilities Other | 7,333,000USD | — | — | 45,000USD | 118,000USD | 1,127,000USD | 374,000USD |
| Non Currrent Assets Other | 1,807,000USD | 1,782,000USD | 1,598,000USD | 267,000USD | 89,999USD | 1,663,000USD | 1,551,000USD |
| Net Working Capital | 88,754,000USD | 32,973,000USD | 32,170,000USD | 103,377,000USD | 189,739,000USD | -1,565,000USD | 45,897,000USD |
| Unclassified Non Current Liabilities | 55,806,000USD | 26,216,000USD | 8,142,000USD | 9,189,000USD | -18,985,000USD | 10,368,000USD | 8,647,000USD |
| Unclassified Equity | 417,169,000USD | 401,341,000USD | 362,333,000USD | 354,749,000USD | 564,369,000USD | 79,800,000USD | 68,377,000USD |
| Short Long Term Debt | — | — | 3,315,000USD | 6,667,000USD | — | 2,333,000USD | — |
| Unclassified Current Liabilities | — | — | -3,315,000USD | -6,667,000USD | -8,751,000USD | -16,065,000USD | — |
| Other Assets | — | — | — | 1,610,000USD | 231,657,000USD | 2,051,000USD | 1,745,000USD |
| Long Term Debt | — | — | — | 3,165,000USD | 9,628,000USD | 7,412,000USD | 9,610,000USD |
| Net Tangible Assets | — | — | — | 105,647,000USD | 185,429,000USD | -83,287,000USD | -29,523,000USD |
| Other Liab | — | — | — | — | 32,631,000USD | 540,000USD | 374,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -218,060,000USD | 0USD | — |
| Unclassified Non Current Assets | — | — | — | — | -226,565,000USD | -2,051,000USD | -1,551,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 675,000USD |
| Stock Based Compensation | 3,809,000USD |
| Change To Account Receivables | -1,000,000USD |
| Change To Liabilities | -3,406,000USD |
| Change In Working Capital | -27,340,000USD |
| Operating Cash Flow | -41,105,000USD |
| Capital Expenditures | -575,000USD |
| Investing Cash Flow | -575,000USD |
| Common Stock Issuance | 36,000USD |
| Unclassified Financing Cash Flow | 40,165,000USD |
| Financing Cash Flow | 40,201,000USD |
| Change In Cash | -1,479,000USD |
| End Cash Flow | 137,859,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,529,000USD | 10,360,000USD | -16,286,999USD | -15,844,000USD | -13,265,000USD | -13,093,000USD | -14,020,000USD | -13,925,000USD |
| Depreciation | 344,000USD | 323,000USD | 340,000USD | 381,000USD | 497,000USD | 375,000USD | 381,000USD | 445,000USD |
| Stock Based Compensation | 2,211,000USD | 2,930,000USD | 1,123,000USD | 1,351,000USD | 1,535,000USD | 1,516,000USD | 1,574,000USD | 1,511,000USD |
| Other Non Cash Items | -1,089,000USD | -21,275,000USD | 16,502,999USD | 2,334,000USD | — | 2,000USD | 34,741,000USD | 1,892,000USD |
| Change To Account Receivables | 5,000,000USD | 12,500,000USD | — | — | — | — | 30,000,000USD | — |
| Change In Working Capital | -12,069,000USD | 5,664,000USD | -18,051,000USD | -2,699,000USD | 40,211,000USD | -2,957,000USD | -36,348,000USD | 31,922,000USD |
| Total Cash From Operating Activities | -22,343,000USD | -1,998,000USD | -17,495,000USD | -14,477,000USD | 28,978,000USD | -14,157,000USD | -13,672,000USD | 19,953,000USD |
| Capital Expenditures | -556,000USD | -95,000USD | 0USD | -401,000USD | -22,000USD | -6,000USD | -9,000USD | -21,000USD |
| Free Cash Flow | -22,899,000USD | -2,093,000USD | -17,495,000USD | -14,878,000USD | 28,956,000USD | -14,163,000USD | -13,681,000USD | 19,932,000USD |
| Total Cashflows From Investing Activities | -556,000USD | -95,000USD | — | -401,000USD | -22,000USD | -6,000USD | -9,000USD | -21,000USD |
| Total Cash From Financing Activities | 35,707,000USD | 35,866,000USD | -285,000USD | 47,362,000USD | 4,832,000USD | 8,202,000USD | -3,000USD | 20,043,000USD |
| Issuance Of Capital Stock | 0USD | 35,828,000USD | -47,318,000USD | 47,318,000USD | 4,827,000USD | 1,000USD | 17,513,000USD | 2,516,000USD |
| Change In Cash | 12,802,000USD | 33,773,000USD | -17,787,000USD | 32,484,000USD | 33,788,000USD | -5,961,000USD | -13,684,000USD | 39,975,000USD |
| Begin Period Cash Flow | 137,531,000USD | 105,565,000USD | 121,551,000USD | 90,861,000USD | 57,073,000USD | 63,034,000USD | 76,718,000USD | 36,743,000USD |
| End Period Cash Flow | 150,333,000USD | 139,338,000USD | 103,764,000USD | 123,345,000USD | 90,861,000USD | 57,073,000USD | 63,034,000USD | 76,718,000USD |
| Other Cashflows From Financing Activities | -1,550,000USD | 35,866,000USD | -285,000USD | 44,000USD | 5,000USD | 4,819,000USD | 4,000USD | 17,548,000USD |
| Unclassified Operating Cash Flow | -2,211,000USD | — | -1,123,000USD | — | — | — | — | -1,892,000USD |
| Unclassified Financing Cash Flow | 37,257,000USD | — | — | — | 2,017,000USD | 3,382,000USD | 4,274,000USD | — |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | -7,000USD | — |
| Sale Purchase Of Stock | — | -80,000USD | 40,000USD | — | 2,810,000USD | — | -4,274,000USD | — |
| Investments | — | — | 0USD | -401,000USD | -22,000USD | -6,000USD | -9,000USD | -21,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -35,036,000USD | -58,241,000USD | -76,404,000USD | -88,222,000USD | -75,800,000USD | -55,219,000USD | -17,311,000USD |
| Depreciation | 1,541,000USD | 1,644,000USD | 1,900,000USD | 1,847,000USD | 1,499,000USD | 1,065,000USD | 240,000USD |
| Stock Based Compensation | 6,939,000USD | 6,434,000USD | 7,382,000USD | 8,424,000USD | 4,958,000USD | 1,296,000USD | 112,000USD |
| Other Non Cash Items | -3,561,000USD | 3,000USD | 160,000USD | 224,000USD | 173,000USD | 165,000USD | 56,000USD |
| Change To Account Receivables | -5,000,000USD | — | — | — | — | — | — |
| Change In Working Capital | 25,125,000USD | 31,782,000USD | -1,658,000USD | 2,004,000USD | -11,803,000USD | 16,602,000USD | 797,000USD |
| Total Cash From Operating Activities | -4,992,000USD | -18,378,000USD | -68,620,000USD | -75,723,000USD | -80,751,000USD | -36,091,000USD | -17,843,000USD |
| Capital Expenditures | -518,000USD | -36,000USD | -486,000USD | -1,867,000USD | -1,100,000USD | -2,188,000USD | -715,000USD |
| Free Cash Flow | -5,510,000USD | -18,414,000USD | -69,106,000USD | -77,590,000USD | -81,851,000USD | -38,279,000USD | -18,558,000USD |
| Total Cashflows From Investing Activities | -518,000USD | -36,000USD | -486,000USD | -1,867,000USD | -1,100,000USD | -2,188,000USD | -715,000USD |
| Net Borrowings | 0USD | -3,382,000USD | -6,752,000USD | -85,000USD | -25,000USD | -99,000USD | 9,952,000USD |
| Total Cash From Financing Activities | 87,775,000USD | 29,196,000USD | -6,550,000USD | -69,000USD | 260,668,000USD | 10,029,000USD | 60,020,000USD |
| Sale Purchase Of Stock | 2,810,000USD | — | 194,000USD | 16,000USD | 261,528,000USD | — | — |
| Issuance Of Capital Stock | 40,655,000USD | 6,825,000USD | 0USD | 116,359,000USD | 261,245,000USD | 9,969,000USD | 50,068,000USD |
| Change In Cash | 82,265,000USD | 10,782,000USD | -75,681,000USD | -77,659,000USD | 178,817,000USD | -28,250,000USD | 41,462,000USD |
| Begin Period Cash Flow | 57,073,000USD | 46,291,000USD | 120,385,000USD | 199,606,000USD | 20,789,000USD | 49,039,000USD | 7,577,000USD |
| End Period Cash Flow | 139,338,000USD | 57,073,000USD | 44,704,000USD | 121,947,000USD | 199,606,000USD | 20,789,000USD | 49,039,000USD |
| Other Cashflows From Financing Activities | 87,775,000USD | 25,753,000USD | 202,000USD | -69USD | 144,419,000USD | 10,128,000USD | 40,116,000USD |
| Unclassified Financing Cash Flow | -2,810,000USD | — | — | — | -145,254,000USD | -9,969,000USD | -40,116,000USD |
| Investments | — | -36,000USD | -995,000USD | -1,867,000USD | -1,100,000USD | -2,188,000USD | -715,000USD |
| Change To Liabilities | — | — | — | 2,070,000USD | -8,435,000USD | 2,926,000USD | 970,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -77,659,000USD | 178,817,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 1,867,000USD | 1,100,000USD | 2,188,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -1,737,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.